Heart Failure and Cardiomyopathies

The Heart Failure (HF) and Cardiomyopathies Learning Pathway at ACC.26 will spotlight the latest advances and practical strategies shaping care across the HF spectrum. Designed to be clinically actionable with clear take-home points, this year's program builds on consistently popular core sessions while introducing timely new topics and interactive formats, such as debates, case-based talks and audience-driven discussions.

This year's highlights include updates on foundational topics such as HFpEF and cardiac amyloidosis, equipping clinicians with the latest science for daily practice. Sessions on implementation and real-world care will explore how to close persistent practice gaps, including a town hall on bridging evidence and outcomes. Attendees will gain practical expertise in advanced therapies and critical care, from precision approaches to cardiogenic shock and exercise hemodynamic testing to updates in transplantation and durable mechanical circulatory support. Finally, sessions on innovation and future directions will examine the role of AI in early detection, evolving strategies for obesity and CKM care, and key debates in therapy selection and cost-effectiveness.

Sessions You Don't Want to Miss:

• HFpEF Decoded: From Complexity to Clarity (Session 205)
• Choose Your Adventure: Cardiogenic Shock and Temporary Mechanical Circulatory Support (Session 217)
• High Stakes and Hard Choices in Addressing Contemporary Dilemmas in ATTR-CM (Session 300)
• Overcoming the Last Mile in Heart Failure: Bridging the Gap Between Evidence and Practice (Session 254)
• Heart Failure and Obesity: Dual Epidemics, Single Strategy? (Session 270)
• Smarter Signals: Early Detection of Heart Failure Using Artificial Intelligence to Improve Patient Outcomes (Session 297)

Join us for state-of-the-art science, engaging discussions, and practical tools to advance the care of patients with HF and cardiomyopathies.